Prashant Kohli
Chief Executive Officer bei ACASTI PHARMA INC.
Vermögen: 73 148 $ am 31.03.2024
Profil
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC.
Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
19.12.2023 | 21 357 ( 0,23% ) | 73 148 $ | 31.03.2024 |
Aktive Positionen von Prashant Kohli
Unternehmen | Position | Beginn |
---|---|---|
ACASTI PHARMA INC. | Chief Executive Officer | 04.04.2023 |
Ehemalige bekannte Positionen von Prashant Kohli
Unternehmen | Position | Ende |
---|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Corporate Officer/Principal | 01.08.2021 |
Ausbildung von Prashant Kohli
Augustana College (Illinois) | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |